EU medtech industry keeps eye on Portuguese treaty moves:
This article was originally published in Clinica
The Portuguese presidency of the EU Council is hoping to secure a political agreement on the European Union treaty by mid-October, and is targeting text sign-off by the end of the year. National leaders were due to meet on September 7 with the aim of strengthening the functioning and management of the 27-member EU. This should enable it to become more influential on a global level, politically and economically, and on an industrial level - with obvious repercussions for the medtech industry, among others. The new treaty, as currently proposed, would provide for a permanent president, and, from 2014, would give national parliaments a greater role. The issue remains highly political, and the text has many opponents.
You may also be interested in...
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.
Skin hygiene is one of several categories where Edgewell Personal Care has a “right to win" after 18 months of renovations, according to the company’s 20 November Investor Day presentation. The firm has doubled its production capacity and has plans for a “full suite” of product innovation to build on Wet Ones’ 60% growth in fiscal 2020.
Considerable value has been assigned to the companies developing coronavirus vaccines. Multiple suppliers and a met clinical need may erode much of that value after the pandemic.